Lee C, Chen S, Lin T
Cancer Res. 1977 Mar;37(3):918-21.
The leukocyte migration inhibition assay was used to detect cell-mediated immune reaction of hepatoma patients. Extraction of 3 pairs of human hepatoma tissue and normal liver tissue was made by 3 M KCI solution, and soluble hepatoma antigens were used to test against leukocytes of 18 hepatoma patients by the leukocyte migration inhibition assay. In all, 25 tests were performed; most of them were allogenic, and only 3 tests were autologous. Migration inhibition was observed in 13 of 25 tests, and there were only a few cases of migration inhibition in the control groups. It was concluded that tumor-associated antigen of human hepatoma was contained in the 3 M KCI extract of hepatoma tissue and that tumor-associated antigen of human hepatoma was shared by some hepatoma patients.
采用白细胞游走抑制试验检测肝癌患者的细胞介导免疫反应。用3M氯化钾溶液提取3对人肝癌组织和正常肝组织,并用可溶性肝癌抗原通过白细胞游走抑制试验检测18例肝癌患者的白细胞。共进行了25次试验;其中大部分是同种异体的,只有3次是自体的。25次试验中有13次观察到游走抑制,而对照组中只有少数几例游走抑制。结论是人肝癌组织的3M氯化钾提取物中含有肝癌相关抗原,且部分肝癌患者存在共同的肝癌相关抗原。